Investigating the appropriate dose of sodium thiopental for induction of anesthesia
Phase 3
- Conditions
- Appropriate dose of sodium thiopental for induction of anesthesia.
- Registration Number
- IRCT20230825059254N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
ASA Class I and II
ASA Class III if it is due to BMI more than 40
BMI more than 25
obtaining informed consent
Exclusion Criteria
Patients with age less than 20 years or more than 60 years
Discontentment with the project
ASA Class IV and V
Patients with unstable hemodynamics, hemorrhagic shock and heart failure
Recent abuse of morphine or any other drugs
Patients with porphyria, asthma, uncontrolled hypertension and hypothyroidism
Patients with lowering of consciousness
Patients with drug allergies
Patients requiring second laryngoscopy or failed intubation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bispectral Index. Timepoint: Before induction of anesthesia, after injection of sodium thiopental, three minutes after induction of anesthesia. Method of measurement: BIS monitoring.
- Secondary Outcome Measures
Name Time Method Heart Rate. Timepoint: Before induction of anesthesia, after injection of sodium thiopental, three minutes after induction of anesthesia. Method of measurement: Pulse oximetry.;Mean Arterial pressure. Timepoint: Before induction of anesthesia, after injection of sodium thiopental, three minutes after induction of anesthesia. Method of measurement: NIBP monitoring.